💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

Anthem ties-up with Walmart for over-the-counter drugs

Published 08/20/2018, 09:04 AM
Updated 08/20/2018, 09:10 AM
© Reuters. The office building of health insurer Anthem is seen in Los Angeles, California
WMT
-
ELV
-
AET
-
HUM
-
UNH
-

(Reuters) - Anthem Inc (N:ANTM) said on Monday it has partnered with Walmart Inc (N:WMT) to launch a program in January 2019 that will allow its Medicare Advantage plan customers to purchase over-the-counter medications from the retailer's stores and website.

Anthem said the program will provide OTC drugs and health-related items, such as first aid supplies, support braces, and pain relievers at reduced costs.

The Medicare Advantage plan, which competes with the traditional Medicare fee-for-service program, provides healthcare coverage to about 17 million Americans and is offered by insurers including UnitedHealth Group Inc (N:UNH), and Aetna Inc (N:AET).

Leerink analyst Ana Gupte said the collaboration emphasizes Anthem's increasing focus and success on Medicare Advantage growth post the margin turnaround, adding the tie-up modestly dampens the likelihood of a near-term Humana deal or JV with Walmart.

Earlier this month, insurer Humana Inc (N:HUM), which has a co-branded Medicare drug plan with Walmart, said it was looking to expand its tie-up with the retailer.

© Reuters. The office building of health insurer Anthem is seen in Los Angeles, California

The Walmart-Humana partnership offers a prescription drug plan that saves up to 20 percent in drug costs for customers.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.